Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 9Completed 3Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1268INDUSTRY 1176NIH 141NETWORK 99OTHER_GOV 16UNKNOWN 3INDIV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Esophageal Neoplasms 9Stomach Neoplasms 7Breast Neoplasms 7Rectal Neoplasms 5Brain Neoplasms 4Neoplasms 3Melanoma 3Lung Neoplasms 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Radiation Injuries 2Pain 2Meningeal Carcinomatosis 2Vomiting 1Varicose Veins 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Tuberculosis 1Thoracic Neoplasms 1Solitary Pulmonary Nodule 1Solid Tumors 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Skin Diseases 1Sarcoidosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polyps 1Non-Muscle Invasive Bladder Neoplasms 1Neutropenia 1Nasopharyngeal Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 1Gemcitabine 1Erlotinib Hydrochloride 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × UNKNOWN × Carcinoma, Non-Small-Cell Lung × Clear all
NCT00880971 2020-10-05

Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung Cancer

ChineseAMS

Phase 3 Completed
394 enrolled
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Thoracic Neoplasms

NCT00600587 2013-06-25

Induction Erlotinib Therapy in Stage III A (N2) Non-Small Cell Lung Cancer (NSCLC)

GuangdongPPH

Phase 2 Completed
24 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01494558 2011-12-19

Study of Etoposide, Cisplatin, and Radiotherapy Versus Paclitaxel, Carboplatin and Radiotherapy to Treat Non-Small Cell Lung Cancer

ChineseAMS

Phase 2/3 Completed
200 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡